Year-End Report

FOLEY HOAG LLP for GENENTECH INC

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Follow-on biologics, S 1695 FDA Reform bills, S 1082, HR 2900

LobbyistCovered position, as disclosed
PAUL KIM N/A
NICK LITTLEFIELD N/A
DAVID MOHLER N/A
BARRETT THORNHILL N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2900 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.